If not hormones - then what?

Australian Family Physician

Volumn 33, Issue 11, 2004, Pages 895-899

  Murkies, Alice ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; BODY TEMPERATURE; DIET; ESTROGEN THERAPY; EXERCISE; FEMALE; HUMAN; LIFESTYLE; MENOPAUSE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RELAXATION TRAINING; REVIEW;

BODY TEMPERATURE; COMPLEMENTARY THERAPIES; DIET; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HUMANS; LIFE STYLE; MENOPAUSE; MIDDLE AGED; RELAXATION TECHNIQUES;

EID: 16644387631     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Davis SR. Identifying and promoting the specific nutrition and physical activity needs of women aged 40 and over. Med J Aust 2000;173(Suppl):S109.
2. Farrell E. Medical choices available for management of menopause. Best Pract Res Clin Endocrinol Metab 2003;17:1-16.
3. Hickie IB. Preventing depression: a challenge for the Australian community. Med J Aust 2002;176:S84-S95.
4. Sambrook PN, Seeman E, Phillips SR, Ebeling PR. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust 2002;176:S1-S16.
5. Strea B, Wells G. Calcium supplementation bone loss in postmenopausal women. Cochrane Library. Issue 2, 2004. Available at: www.ncis.com.au/cochrane/index.asp.
6. Guthrie JR, Ball M, Murkies A, Dennerstein L. Dietary phytoestrogen intake in mid-life Australian born women: relationship to health variables. Climacteric 2000;4:254-261.
7. Position statement of the North American Menopause Society. Treatment of menopause associated vasomotor symptoms. Menopause 2004;11:11-33.
8. Adams J, Sibritt DW, Easthope G, Young A. The profile of women who consult alternative health practitioners in Australia. Med J Aust 2003;179:297-300.
9. van de Weijer PH, Barentsen R. Isoflavones from red clover (promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;25:187-193.
10. Wuttke W, Seidlova-Wuttke D, Gorkow C. The cimicifuga preparation BNO 1055 vs conjugated oestrogen in double blind placebo controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(Suppl 1):S67-S77.
11. Stoll W. Phytotherapy influences atrophic vaginal epithelium: double blind study cimicifuga vs estrogenic substances (in German). Therapeutiken 987;1:23-31.
12. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999;94:225-228.
13. Linde K, Mulrow CD. St John's wort for depression. Cochrane Review. Issue 2, 2004. Available at: www.ncis.com.au/cochrane/index.asp.
14. Johnston SL, Farrell SA, Bouchard C, et al. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26:503-508.
15. Panya KJ, Raubertas RF, Fynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen induced hot flashes: a University of Rochester Cancer Centre community clinical oncology program study. Ann Intern Med 2000;132:788-793.
16. Loprinzi CL, Kluger JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-2063.
17. Steams V, Beebe KL, Iyengar M, Dube E. Paroxetene controlled release in the treatment of menopausal hot flashes: a randomised controlled trial. JAMA 2003;289:2827-2834.